Immunopathology of hepatitis C
- 1 March 1997
- journal article
- review article
- Published by Springer Nature in Springer Seminars in Immunopathology
- Vol. 19 (1) , 57-68
- https://doi.org/10.1007/bf00945025
Abstract
Hepatitis C virus (HCV) infection becomes persistent in the majority of instances in the face of a Immoral and cellular immune response, and persistent HCV infection is associated with chronic hepatitis. In particular, cytotoxic T lymphocytes (CTL), crucial in the eradication of virus-infected cells, have been observed in the liver and the peripheral blood of chronically infected patients, suggesting that CTL cannot completely eliminate the virus, and may contribute to chronic liver injury. In this review, the potential host and the viral factors involved in the pathogenesis of chronic HCV infection will be discussed with emphasis on the HLA-A2 restricted peripheral blood CTL response and its relationship to liver disease and viral load.Keywords
This publication has 97 references indexed in Scilit:
- Cytotoxic T Lymphocyte Response and Viral Load in Hepatitis C Virus InfectionHepatology, 1997
- One Step Ahead of the Game: Viral Immunomodulatory MoleculesAnnual Review of Immunology, 1996
- Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T LymphocytesImmunity, 1996
- Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.Journal of Clinical Investigation, 1995
- Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variantsNature, 1994
- Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis CHepatology, 1994
- T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infectionsHepatology, 1994
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989